Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shaanxi Tianning Pharmaceutical Co., Ltd. is a specialized Chinese pharmaceutical company focused on the development, manufacturing, and commercialization of Traditional Chinese Medicine (TCM). As a key subsidiary of the publicly listed Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd., the company operates from its headquarters in Shaanxi Province. Its product portfolio is anchored by its flagship therapy, Compound Zaofan Pills (复方皂矾丸), which is widely utilized in China for treating hematological conditions such as aplastic anemia and leukopenia. Beyond hematology, the company produces various TCM formulations for gastrointestinal and neurological health. Tianning Pharmaceutical maintains modern, GMP-certified facilities and integrates traditional herbal knowledge with contemporary pharmaceutical standards. The company plays a significant role in the domestic supply chain for specialized TCM treatments in the blood disorder space.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 天宁制药.